MYC and Miyoshi myopathy: The heterogeneity and genomic similarity with human MM create an opportunity for future investigations aimed to longitudinally track the genomic and tumor microenvironment evolution of Vk*MYC MM over time that could inform on key drivers of the progression from SMM to MM human.